Robert E. Claypoole is the President and Chief Executive Officer at Bioventus Class A Inc., a global leader in innovative solutions for active healing. With a distinguished career spanning over three decades, Claypoole has a proven track record of driving growth and innovation in the medical technology industry. Prior to joining Bioventus, he held several senior leadership positions at Stryker Corporation, where he significantly contributed to the company's expansion and success. His strategic vision and operational expertise have been instrumental in positioning Bioventus as a frontrunner in the orthobiologics and wound care markets. At Bioventus, Claypoole has been pivotal in steering the company through a period of rapid growth and transformation. Under his leadership, Bioventus has successfully expanded its product portfolio and global footprint, enhancing its ability to deliver cutting-edge solutions to patients worldwide. Claypoole's commitment to innovation is evident in the company's ongoing investment in research and development, which has led to the introduction of several groundbreaking products that address unmet medical needs. His focus on fostering a culture of excellence and collaboration has also been key to attracting top talent and maintaining high employee satisfaction within the organization. In addition to his role at Bioventus, Claypoole is actively involved in the broader healthcare community. He serves on the board of directors for several industry organizations and is a frequent speaker at medical technology conferences, where he shares insights on industry trends and future opportunities. His leadership extends beyond the corporate realm, as he is dedicated to mentoring the next generation of healthcare leaders and advocating for policies that support innovation and patient care. Claypoole's contributions to Bioventus and the medical technology field have earned him widespread recognition, cementing his reputation as a visionary leader committed to advancing the frontiers of healthcare.